Arterial embolism
Arterial embolism refers to a blood clot or foreign matter that enters a blood vessel and becomes an embolus. As blood flow stops in a peripheral artery or visceral artery of similar smaller caliber, it causes blood flow obstruction.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
More common in men over 45 years old -
Related symptoms:
Intermittent claudication lower back pain buttocks pain iliac fossa pain calf muscle pain and tenderness -
Concurrent disease:
Related Drugs
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Jinzhou Jiutai Pharmaceutical Co., Ltd.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Pentoxifylline Sodium Chloride Injection
Indication: ① Cerebral blood circulation disorders such as transient cerebral ischemic attack, sequelae of stroke, and brain dysfunction caused by cerebral ischemia; ② Peripheral blood circulation disorders such as thromboembolic vasculitis, abdominal arterial blood circulation disorders, intermittent claudication or rest pain; ③ Inner ear circulation disorders such as sudden deafness, senile tinnitus and deafness; ④ Ocular blood circulation disorders such as diabetic retinal artery embolism.
Manufacturer:
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: It is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Ma'anshan Fengyuan Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Harbin Shengji Pharmaceutical Co., Ltd.
Urokinase for injection
Indication: The product is mainly used for thrombolytic therapy of thromboembolic diseases, including acute extensive pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebral vascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other patients with severe iliac-femoral vein thrombosis with peripheral arterial embolism symptoms. It is also used to prevent thrombosis after artificial heart valve surgery, maintain patency of vascular cannulation and chest and pericardial drainage tubes, etc. The efficacy of thrombolysis requires subsequent heparin anticoagulation to maintain.
Manufacturer:
Wuhan Humanwell Pharmaceutical Co., Ltd.
Related Ingredients